FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
Barclays analyst Peter Lawson downgraded Spring Works Therapeutics (NASDAQ: SWTX) from Overweight to Equalweight with a price target of $47.00 (from $63.00).
For an analyst ratings summary and ratings history on Spring Works Therapeutics... More

